ATX Technologies Inc.

ARKANSAS PUBLIC SERVICE COMMISSION REPORTS FILING IN MATTER OF ANNUAL DETERMINATION OF INTEREST RATE APPLICABLE TO UTILITY CUSTOMER DEPOSITS
US Fed News Service, Including US State News; 11/5/2009; 2860 words; ...sponte AT&T Corp. Party sua sponte ATX Licensing, Inc. Party sua sponte Bandwidth.com CLEC...Telcom, Inc. Party sua sponte Convergia, Inc. Party sua sponte Conversant Technologies, Inc. Party sua sponte Covista, Inc. Party...

Other News To Note.
BIOWORLD Today; 11/4/2009; 2691 words; o Agilent Technologies Inc., of Palo Alto, Calif...microarray and microfluidics technology platforms to develop...2002.) o Bioenvision Inc., of New York, entered...ChemGenex Therapeutics Inc., of Menlo Park, Calif...proarrhythmic effects of ATX-II, a naturally occurring...

KYTHERA Biopharmaceuticals Announces Initiation of First-in-Human Trial for ATX-104 - a Light-Activated Facial Contouring Agent.
Biotech Week; 9/30/2009; 915 words; ...Biopharmaceuticals, Inc.). "We are very excited to move ATX-104 into the clinic...based on a proprietary technology co-developed by...facial contouring (ATX-104), pigmentation modulation (ATX-202), and multiple...Biopharmaceuticals Inc. This article was...

AVI-SPL Certified by Polycom to Deliver Customized Immersive Telepresence Solutions.
Science Letter; 9/29/2009; 1060 words; ...certification from Polycom, Inc., a leading telepresence...8482; (Polycom ATX) 300, to help organizations...customization, Polycom ATX solutions are standards...systems. With Polycom ATX systems, industry-leading technology components (codecs...

KYTHERA Biopharmaceuticals Announces Initiation of First-in-Human Trial for ATX-104 - A Light-Activated Facial Contouring Agent.
Business Wire; 9/15/2009; 675 words; ...KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today announced...histological effects of ATX-104, a light-activated...104." About ATX-104 ATX-104 is a light-activated...based on a proprietary technology co-developed by KYTHERA...Johns Hopkins University. ATX-104 is designed to be...